PANACEA BIOTEC
Back to Balance Sheet
|
PANACEA BIOTEC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹104 Cr | ₹265 Cr | ₹271 Cr | ₹85 Cr | ₹960 Cr |
What is the latest Total Non-Current Liabilities ratio of PANACEA BIOTEC ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹104 Cr |
| Mar2024 | ₹265 Cr |
| Mar2023 | ₹271 Cr |
| Mar2022 | ₹85 Cr |
| Mar2021 | ₹960 Cr |
How is Total Non-Current Liabilities of PANACEA BIOTEC Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹104 Cr | -60.91 | |
| Mar2024 | ₹265 Cr | -2.07 | |
| Mar2023 | ₹271 Cr | 218.11 | |
| Mar2022 | ₹85 Cr | -91.14 | |
| Mar2021 | ₹960 Cr | - | |
Compare Total Non-Current Liabilities of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹3,316.9 Cr | 35.8% | 35.7% | -1.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,933.0 Cr | -0.7% | -3.6% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,833.0 Cr | 1.1% | -1.2% | -0.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,549.0 Cr | 1.6% | 1.4% | 36.7% | Stock Analytics | |
| CIPLA | ₹113,155.0 Cr | 0.7% | 2.6% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,652.0 Cr | -0.9% | -2.5% | 1.2% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | 35.8% |
35.7% |
-1.9% |
| SENSEX | -0.7% |
-3.6% |
-9.1% |
You may also like the below Video Courses